These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10523942)

  • 21. Adoption of spironolactone therapy for older patients with heart failure and left ventricular systolic dysfunction in the United States, 1998-2001.
    Masoudi FA; Gross CP; Wang Y; Rathore SS; Havranek EP; Foody JM; Krumholz HM
    Circulation; 2005 Jul; 112(1):39-47. PubMed ID: 15983243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of the addition of a low dose of spironolactone on brain natriuretic peptide plasma level and cardiopulmonary function in patients with moderate congestive heart failure.
    Feola M; Menardi E; Ribichini F; Vado A; Deorsola A; Ferrero V; Visconti G; Milanese U; Uslenghi E
    Med Sci Monit; 2003 Aug; 9(8):CR341-5. PubMed ID: 12942029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Therapy of heart insufficiency using aldosterone antagonists].
    Krauss J
    Z Allgemeinmed; 1973 Jul; 49(21):989-91. PubMed ID: 4756071
    [No Abstract]   [Full Text] [Related]  

  • 24. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
    Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curriculum in cardiology: Integrated diagnosis and management of diastolic heart failure (Am Heart J 2007;153:189-200).
    Jolobe OM
    Am Heart J; 2007 Jul; 154(1):e5; author reply e7. PubMed ID: 17584543
    [No Abstract]   [Full Text] [Related]  

  • 26. Slow adoption of helpful heart failure drug. Many people who could benefit from spironolactone aren't getting it.
    Harv Heart Lett; 2010 Feb; 20(6):2. PubMed ID: 20376944
    [No Abstract]   [Full Text] [Related]  

  • 27. [Aldosterone antagonist].
    Yamazaki T
    Nihon Rinsho; 2006 May; 64(5):917-20. PubMed ID: 16689374
    [No Abstract]   [Full Text] [Related]  

  • 28. [Randomized Aldactone Evaluation Study (RALES)].
    Uchida K; Nakano S; Kigoshi T
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():330-5. PubMed ID: 15813090
    [No Abstract]   [Full Text] [Related]  

  • 29. Fracture risk in men with congestive heart failure risk reduction with spironolactone.
    Carbone LD; Cross JD; Raza SH; Bush AJ; Sepanski RJ; Dhawan S; Khan BQ; Gupta M; Ahmad K; Khouzam RN; Dishmon DA; Nesheiwat JP; Hajjar MA; Chishti WA; Nasser W; Khan M; Womack CR; Cho T; Haskin AR; Weber KT
    J Am Coll Cardiol; 2008 Jul; 52(2):135-8. PubMed ID: 18598893
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist?
    Bansal S; Lindenfeld J; Schrier RW
    Circ Heart Fail; 2009 Jul; 2(4):370-6. PubMed ID: 19808361
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
    Fuster D; Frey FJ; Ferrari P
    Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The process of drug development. The "case" of spironolactone].
    De Feo S; Opasich C; Volpi A; Tavazzi L
    Ital Heart J Suppl; 2002 Feb; 3(2):178-86. PubMed ID: 11926024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cardiac insufficiency in the aged].
    Kubicek F
    Wien Med Wochenschr; 1979 Oct; 129(18):501-4. PubMed ID: 534365
    [No Abstract]   [Full Text] [Related]  

  • 34. Drug therapy in chronic heart failure.
    Jolobe O
    Postgrad Med J; 2004 Apr; 80(942):247. PubMed ID: 15082857
    [No Abstract]   [Full Text] [Related]  

  • 35. Aldosterone antagonism and atrial fibrillation: time for clinical assessment?
    Nattel S
    Eur Heart J; 2005 Oct; 26(20):2079-80. PubMed ID: 16141259
    [No Abstract]   [Full Text] [Related]  

  • 36. [Spironolactone in digitalis-requiring cardiac insufficiency following pacemaker implantation].
    Sabin G; Klüsener W
    Med Klin; 1981 Jan; 76(1):20-3. PubMed ID: 7254119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diuretics in the therapy of chronic cardiac insufficiency].
    Herbinger W
    Wien Med Wochenschr; 1982 Oct; 132(19):457-64. PubMed ID: 7179996
    [No Abstract]   [Full Text] [Related]  

  • 38. Moderate renal insufficiency does not attenuate the clinical benefit of aldosterone antagonists in heart failure.
    Kiernan MS; Konstam MA
    J Am Coll Cardiol; 2012 Nov; 60(20):2090-1. PubMed ID: 23083776
    [No Abstract]   [Full Text] [Related]  

  • 39. Efficacy of spironolactone therapy in patients with heart failure with normal ejection fraction.
    Ozhan H; Balaban Y
    Heart; 2010 May; 96(10):791; author reply 791. PubMed ID: 20448132
    [No Abstract]   [Full Text] [Related]  

  • 40. [Current problems in the diagnosis and therapy of cardiac insufficiency].
    Urbaszek W; Springfeld K
    Z Arztl Fortbild (Jena); 1982 Jun; 76(11):477-82. PubMed ID: 6126964
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.